WPCS International Incorporated (NASDAQ: WPCS) announced financial results for the fiscal year 2013 first quarter ended July 31, 2012 on Friday, September 14th, after market hours. Highlights: EBITDA of approximately $695,000 compared to an EBITDA loss of $7.1 million in preceding quarter ended April 30, 2012. Net income of approximately $994,000 or $0.14 per diluted […]
Generex Biotechnology Corporation (GNBT): Trading Alert
Generex Biotechnology Corporation (GNBT) announced today presentation of early results from an efficacy study of an immunotherapeutic in triple negative breast cancer patients from its wholly owned subsidiary, Antigen Express, Inc. The results will be made at the 2012 ASCO (American Society of Clinical Oncology) Breast Cancer Symposium on September 14th. Dr. Elizabeth Mittendorf, the […]
DARA BioSciences (DARA): Granted Exclusive U.S. Commercial Rights to Gelclair®
DARA BioSciences, Inc. (DARA) announced today that company entered into an exclusive agreement with The Helsinn Group of Switzerland for U.S. commercial rights to Gelclair®. DARA plans to launch Gelclair, FDA-cleared product indicated for the treatment of oral mucositis, in the first quarter of 2013. Oral mucositis market is approximately 400,000 patients annually according to […]
Houston American Energy Corp. (HUSA): Unusual Volume Alert
Houston American Energy Corp. (NYSE: HUSA) shares ended a trading session with gains of over 29% and closed at the high of the day. HUSA has posted on the Company’s web site presentation slides reflecting site, seismic and geological data with respect to its holdings in the Serrania area in Colombia. Sophisticated investors were curious […]
Peregrine Pharmaceuticals (PPHM): Share Price Correction on the Way
By Mr. BiotechIll, Guest Author Shares of Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) gain almost half their value after announcement that interim results were presented from its 121 patient randomized, double-blind, placebo-controlled Phase IIb trial in patients with refractory non-small cell lung cancer (NSCLC). At glance: Data show statistically significant improvement in overall survival for patients receiving […]
United Resource Holdings Group (URHG): Conditional Approval of NDEP Water Pollution Control Permit
News: United Resource Holdings Group, Inc. (URHG) announced today that the NDEP (Nevada Division of Environmental Protection) has granted conditional approval of URHG’s Nevada Water Pollution Control Permit Application for URHG’s Dun Glen Placer Mine project. Issuance of the permit is anticipated on or about October 15, 2012 . Mark A. Kersey , URHG’s Chief […]
Quiksilver Inc. (ZQK): Third Quarter Profit Topped Estimates
Quiksilver Inc.’s (NYSE: ZQK) shares jumped today after the clothing company reported a third-quarter profit that topped estimates: Americas revenue increased 10% to $286.1 million from $260.2 million, and was up 12% in constant currency. Europe revenue decreased 13% to $154.1 million from $176.4 million, and was up modestly in constant currency. Asia Pacific revenue […]
Office Depot Inc. (ODP): Affirmed Full-Year 2012 Outlook
Office Depot Inc. (NYSE: ODP) shares gained 12% as of 11 AM EDT regardless of the “south” trading direction in overall retail sector. The office-supplies chain left unchanged its full-year 2012 outlook at a Goldman Sacks Global Retailing Conference: The Company expects to achieve full-year 2012 adjusted EBIT in the $125 to $135 million range, […]
KMA Global Solutions International (KMAG): Noteworthy Buzz of the Street
KMA Global Solutions International, Inc. (KMAG) stock made a second remarkable run-up this year from low $.003s per share to $.02 & has been consolidated for a month at around cent level. KMAG shares are going higher on investor expectations of the KMA Global Solutions’s sales result for the third quarter of 2012. Preceding KMA […]
Entest BioMedical (ENTB): Day-Trading Alert and Nothing Else…
Entest BioMedical (ENTB) security has been alerted to our Twitter followers after market open as a technical day-trading opportunity. ENTB shares jumped as a high of $.0057 from the $.0032 entry representing 78% in daily gains. Entest BioMedical’s stock traded 3.8 fold of its 10day average volume as of 12:45 EST. Notice for the ENTB’s investors […]